| | Contents | |
| | | |
| |
| | Preface | XVII |
| | Foreword | XIX |
| | List of Contributors | XXI |
| Part I | Bone | 1 |
| 1 | Mineralization of Bone: An Active or Passive Process? Thorsten Schinke and Michael Amling | 3 |
| | Abstract | 3 |
| 1.1 | Physiological and Pathological Mineralization | 3 |
| 1.2 | Inhibitors of Pathological Mineralization | 5 |
| 1.3 | Activators of Physiological Mineralization | 6 |
| 1.4 | The Key Role of Pyrophosphate | 9 |
| 1.5 | The Mysterious Role of the Endopeptidase Phex | 11 |
| 1.6 | Concluding Remarks | 13 |
| | References | 14 |
| 2 | Bone Morphogenetic Proteins Walter Sebald, Joachim Nickel, Axel Seher, and Thomas D. Müller | 19 |
| | Abstract | 19 |
| 2.1 | Introduction | 19 |
| 2.2 | What is a Bone Morphogenetic Protein? | 21 |
| 2.3 | BMP Receptors are Composed of Diverse Type I and Type II Receptor Chains | 23 |
| 2.4 | The Basic Signaling Mechanism is the Same for BMPs and other TGF- -like Proteins | 24 |
| 2.5 | Biochemistry and Cell Biology of Receptor Specificity | 25 |
| 2.6 | Structural Basis for Specificity and Affinity of BMP Receptor Interaction | 27 |
| 2.7 | What We Can Do with BMPs: The Engineering of BMP-2 and GDF-5 Variants | 29 |
| | References | 32 |
| 3 | Biomechanics of Bones: Modeling and Computation of Bone Remodeling Udo Nackenhorst | 35 |
| | Abstract | 35 |
| 3.1 | Introduction | 35 |
| 3.2 | The Biomechanical Equilibrium Approach | 36 |
| 3.3 | A Computational Multi-Scale Approach for Cortical Bone | 42 |
| 3.3.1 | Closed Nano-to-Meso Control Circuit Approach | 43 |
| 3.3.2 | Sub-Cellular Length-Scale | 44 |
| 3.3.3 | Micro-Scale Model (Single Osteon) | 45 |
| 3.3.4 | Meso-Scale Model of Cortical Bone | 45 |
| 3.4 | Conclusions | 46 |
| | References | 47 |
| 4 | Direct X-Ray Scattering Measurement of Internal Stresses and Strains in Loaded Bones Stuart R. Stock and Jonathan D. Almer | 49 |
| | Abstract | 49 |
| 4.1 | Introduction | 49 |
| 4.2 | Background | 50 |
| 4.2.1 | X-Ray Scattering | 50 |
| 4.2.2 | Strains and Stresses | 51 |
| 4.3 | Methods | 51 |
| 4.3.1 | Specimens and Geometry | 51 |
| 4.3.2 | Analysis of Two-Dimensional (2-D) Scattering Patterns | 53 |
| 4.3.3 | X-Ray Elastic Constants and Strain--Stress Conversion | 55 |
| 4.4 | Examples of Data and Analysis | 55 |
| 4.5 | Discussion and Future Directions | 56 |
| | References | 57 |
| 5 | Osteoporosis and Osteopetrosis Adele L. Boskey | 59 |
| | Abstract | 59 |
| 5.1 | Introduction: Two Distinct Diseases with Common Features | 59 |
| 5.1.1 | Comparisons of Clinical Features of Osteoporosis and Osteopetrosis | 60 |
| 5.1.1.1 | Histology | 60 |
| 5.1.1.2 | Radiography | 61 |
| 5.1.2 | Comparisons of Bone Mineral Properties in Osteoporosis and Osteopetrosis | 62 |
| 5.2 | Animal Models of Osteoporosis and Osteopetrosis | 63 |
| 5.2.1 | Osteoporosis | 63 |
| 5.2.1.1 | Rodent Models | 63 |
| 5.2.1.2 | Non-Rodent Models | 66 |
| 5.2.2 | Osteopetrosis | 66 |
| 5.2.2.1 | Rodent Models | 67 |
| 5.2.2.2 | Other Osteopetrotic Models | 68 |
| 5.3 | The Cellular and Molecular Bases of Osteopetrosis and Osteoporosis | 70 |
| 5.3.1 | Osteoporosis | 70 |
| 5.3.2 | Osteopetrosis | 72 |
| 5.4 | Biomineralization in Osteopetrosis and Osteoporosis | 74 |
| | References | 75 |
| 6 | Biomimetic Bone Substitution Materials Matthias Epple | 81 |
| | Abstract | 81 |
| 6.1 | The Clinical Need for Bone Substitution Materials | 81 |
| 6.2 | Synthetic Materials Used for Bone Substitution | 82 |
| 6.3 | Ceramics and Bone Cements | 84 |
| 6.4 | Polymers | 86 |
| 6.4.1 | PMMA-Based Materials | 86 |
| 6.4.2 | Polyester-Based Materials | 86 |
| 6.5 | Metals | 87 |
| 6.6 | Composites | 87 |
| 6.7 | Bone Substitutes of Biological Origin | 87 |
| 6.8 | Biological Functionalization of Synthetic Materials | 90 |
| 6.9 | An Example of a Synthetic Biomimetic Bone Substitution Material | 90 |
| 6.10 | Conclusions and Future Developments | 91 |
| | References | 92 |
| 7 | Simulated Body Fluid (SBF) as a Standard Tool to Test the Bioactivity of Implants Tadashi Kokubo and Hiroaki Takadama | 97 |
| | Abstract | 97 |
| 7.1 | Introduction | 97 |
| 7.2 | Qualitative Correlation of Bone-Bonding Bioactivity of a Material with Apatite Formation on its Surface in SBF | 98 |
| 7.3 | Quantitative Correlation of Bone-Bonding Bioactivity and Apatite-Forming Ability in SBF | 100 |
| 7.4 | Ion Concentrations of SBF | 101 |
| 7.5 | Materials Able to Form Apatite | 102 |
| 7.6 | Composition and Structure of Apatite | 103 |
| 7.7 | Mechanism of Bonding of Bioactive Material to Bone | 104 |
| 7.8 | Mechanisms of Apatite Formation | 105 |
| 7.9 | Summary | 106 |
| | References | 106 |
| 8 | Stimulation of Bone Growth on Implants by Integrin Ligands Mónica López-García and Horst Kessler | 109 |
| | Abstract | 109 |
| 8.1 | Introduction | 109 |
| 8.1.1 | Biomimetic Materials for Implant Technology | 109 |
| 8.1.2 | Integrins and RGD Sequence | 110 |
| 8.1.3 | Natural Proteins or Synthetic Peptides as Cell-Adhesive Molecules? | 111 |
| 8.1.4 | Integrin-Mediated Cell Adhesion | 112 |
| 8.2 | Improvements in Implant-Osseointegration by Surface Modification with Integrin Ligands | 115 |
| 8.2.1 | Mechanisms of Bone Grafting | 115 |
| 8.2.2 | Modifications on Implant Surfaces to Improve its Osseointegration | 116 |
| 8.2.3 | Structure of the Coating Molecules | 117 |
| 8.2.4 | Stimulation of Osteoblasts Adhesion and Proliferation on Implants Promoted by Integrin Ligands | 118 |
| 8.2.4.1 | Poly(methyl methacrylate) | 118 |
| 8.2.4.2 | Silks | 120 |
| 8.2.4.3 | Titanium | 120 |
| 8.2.4.4 | RGD Mimetics | 121 |
| 8.3 | Conclusions | 123 |
| | References | 123 |
| 9 | Biochemical and Pathological Responses of Cells and Tissue to Micro- and Nanoparticles from Titanium and other Materials Fumio Watari, Kazuchika Tamura, Atsruro Yokoyama, Kenichiro Shibata, Tsukasa Akasaka, Bunshi Fugetsu, Kiyotaka Asakura, Motohiro Uo, Yasunori Totsuka, Yoshinori Sato, and Kazuyuki Tohji | 127 |
| | Abstract | 127 |
| 9.1 | Introduction | 128 |
| 9.2 | Materials and Methods | 128 |
| 9.2.1 | Specimens | 128 |
| 9.2.2 | Dissolution Testing of Ti Particles | 129 |
| 9.2.3 | Probe Cells | 129 |
| 9.2.4 | Biochemical Analyses of Cellular Reactions to Materials | 129 |
| 9.2.5 | Animal Experiments | 129 |
| 9.3 | Results | 130 |
| 9.3.1 | Dependence of Tissue Reaction In Vivo on Material Macroscopic Size | 130 |
| 9.3.2 | Effect of Particle Size on Biocompatibility | 130 |
| 9.3.2.1 | Size Distribution of the Abraded Particles | 130 |
| 9.3.2.2 | Particle Size Dependence In Vitro | 131 |
| 9.3.2.3 | Particle Size Dependence In Vivo | 133 |
| 9.3.2.4 | Material Dependence of the Particle Size Effect In Vitro | 135 |
| 9.3.2.5 | Material Dependency of Tissue Reaction to Particles In Vivo | 135 |
| 9.3.3 | Shape Effect | 136 |
| 9.3.4 | The Origin of the Particle Size Effect | 137 |
| 9.3.5 | Toxicity Level of Particle Size Effect for Bioactive and Bioinert Materials | 138 |
| 9.3.6 | Nanotoxicology | 139 |
| 9.3.6.1 | Size-Dependent Stimulus Down to Nanometer Size | 139 |
| 9.3.6.2 | Internal Diffusion of Nanoparticles | 139 |
| 9.3.6.3 | Toxicity-Enhancing Effects of Biostimulatory Materials by Nanosizing | 140 |
| 9.4 | Discussion | 140 |
| 9.4.1 | Particle Size-Dependence of Cytotoxicity | 140 |
| 9.4.2 | Particle Size-Dependence in Soft Tissues | 141 |
| 9.4.3 | Comparison of Ti, Fe, and Ni Particles | 141 |
| 9.4.4 | The Effect of Micro-/Nanosizing on Biological Reactions | 142 |
| 9.4.5 | Terminology on “Nanotoxicology” | 143 |
| | References | 143 |
| 10 | Tissue Engineering of Bone Hans-Peter Wiesmann, Beate Lüttenberg, and Ulrich Meyer | 145 |
| | Abstract | 145 |
| 10.1 | Tissue Engineering: What Does it Mean? | 145 |
| 10.2 | Components of Bone Tissue Engineering | 147 |
| 10.2.1 | Osteoblasts | 147 |
| 10.2.2 | Bone Marrow Cells | 148 |
| 10.2.3 | Marrow-Derived Stem Cells | 148 |
| 10.2.4 | Vascular Cells | 149 |
| 10.2.5 | Scaffold Design and Cell Compatibility | 149 |
| 10.2.6 | Bioreactors | 150 |
| 10.2.7 | In-Vitro Cell Stimulation | 150 |
| 10.2.7.1 | Biophysical Stimulation | 150 |
| 10.2.7.2 | Biochemical Stimulation | 151 |
| 10.3 | Bone Biomineralization in Tissue Engineering Ex Vivo and In Vivo | 151 |
| 10.3.1 | Principles of ECM Biomineralization | 151 |
| 10.3.2 | Principles of Bone Formation | 152 |
| 10.3.3 | Particular Features of Extracorporeal Biomineralization | 153 |
| 10.4 | Clinical Demands | 153 |
| 10.5 | Future Aspects | 154 |
| | References | 155 |
| Part II | Teeth | 157 |
| 11 | Formation of Teeth Katharina Reichenmiller and Christian Klein | 159 |
| | Abstract | 159 |
| 11.1 | Introduction | 159 |
| 11.2 | Odontogenesis | 163 |
| 11.2.1 | Genes Involved in Odontogenesis | 165 |
| 11.2.2 | Stem Cells | 165 |
| 11.3 | Dentinogenesis | 165 |
| 11.3.1 | Mantle and Circumpulpal Dentin | 166 |
| 11.3.2 | Intertubular Dentin | 168 |
| 11.3.3 | Peritubular Dentin | 168 |
| 11.4 | Amelogenesis | 170 |
| 11.5 | Cementogenesis | 172 |
| 11.5.1 | Acellular Extrinsic Fiber Cementum (AEFC) | 172 |
| 11.5.2 | Cellular Intrinsic Fiber Cementum (CIFC) | 173 |
| 11.5.3 | Cellular Mixed Stratified Cementum (CMSC) | 174 |
| 11.5.4 | Acellular Intrinsic Fiber Cementum (AIFC) | 174 |
| 11.6 | Acknowledgments | 174 |
| | References | 174 |
| 12 | The Structure of Teeth: Human Enamel Crystal Structure Frédéric Cuisinier and Colin Robinson | 177 |
| | Abstract | 177 |
| 12.1 | Introduction | 177 |
| 12.2 | HRTEM Observations | 178 |
| 12.3 | AFM Observations | 179 |
| 12.4 | Discussion | 181 |
| 12.5 | Conclusions | 182 |
| | References | 182 |
| 13 | Design Strategies of Human Teeth: Biomechanical Adaptations Paul Zaslansky and Steve Weiner | 183 |
| | Abstract | 183 |
| 13.1 | Introduction | 183 |
| 13.2 | Deformation of Whole Teeth under Load | 185 |
| 13.3 | Mechanical Behavior of the Enamel Cap | 191 |
| 13.4 | The Role of Crown Dentin During Load Bearing | 194 |
| 13.5 | The Role of the Root and Supporting Structures | 196 |
| 13.6 | Broader Implications and Conclusions | 198 |
| | References | 200 |
| 14 | Clinical Aspects of Tooth Diseases and their Treatment Peter Gängler and Wolfgang H. Arnold | 203 |
| | Abstract | 203 |
| 14.1 | Introduction | 203 |
| 14.2 | Tooth Development and Developmental Anomalies | 206 |
| 14.2.1 | Developmental Features and Elemental Analysis of Early Mineralization | 207 |
| 14.2.2 | Developmental Anomalies | 210 |
| 14.3 | Dental Caries | 212 |
| 14.4 | Periodontal Diseases | 216 |
| 14.5 | Dental Trauma | 220 |
| 14.5.1 | Acute Dental Trauma | 220 |
| 14.5.2 | Chronic Dental Trauma | 220 |
| | References | 221 |
| 15 | Dental Caries: Quantifying Mineral Changes Susan M. Higham and Philip W. Smith | 223 |
| | Abstract | 223 |
| 15.1 | Introduction | 223 |
| 15.2 | Enamel Caries | 224 |
| 15.3 | Dentine Caries | 224 |
| 15.4 | Analyzing Mineral Changes in Dental Caries | 225 |
| 15.4.1 | Transverse Microradiography | 226 |
| 15.4.2 | TMR Studies | 227 |
| 15.5 | Quantitative Light-Induced Fluorescence | 229 |
| 15.5.1 | In Vitro QLF Studies | 231 |
| 15.5.2 | In Vivo QLF Studies | 234 |
| | References | 236 |
| 16 | Periodontal Regeneration Hom-Lay Wang and Lakshmi Boyapati | 239 |
| | Abstract | 239 |
| 16.1 | Definitions | 239 |
| 16.2 | Periodontal Wound Healing | 240 |
| 16.2.1 | Wound-Healing Principles | 240 |
| 16.2.2 | Compartmentalization | 241 |
| 16.2.3 | Evaluating Regeneration | 241 |
| 16.3 | Techniques Used for Regeneration | 241 |
| 16.3.1 | Root Surface Biomodification | 241 |
| 16.3.1.1 | Root Surface Conditioning | 241 |
| 16.3.2 | Bone Replacement Grafts | 242 |
| 16.3.2.1 | Autografts | 243 |
| 16.3.2.2 | Allografts | 243 |
| 16.3.2.3 | Xenografts | 245 |
| 16.3.2.4 | Alloplasts | 245 |
| 16.3.3 | Guided Tissue Regeneration | 246 |
| 16.3.3.1 | Non-Absorbable Membranes | 246 |
| 16.3.3.2 | Absorbable Membranes | 246 |
| 16.3.4 | Biologic Modifiers | 248 |
| 16.3.4.1 | Growth Factors/Cytokines | 248 |
| 16.3.4.2 | Bone Morphogenetic Proteins (BMPs) | 248 |
| 16.3.4.3 | Pep-Gen p-15 | 249 |
| 16.3.4.4 | Enamel Matrix Derivative (EMD) | 249 |
| 16.4 | Factors Influencing GTR Success | 249 |
| 16.4.1 | Patient Factors | 251 |
| 16.4.2 | Defect/Local Factors | 251 |
| 16.4.3 | Treatment Factors | 252 |
| 16.4.4 | Postoperative Care | 252 |
| 16.5 | Surgical Principles | 253 |
| 16.5.1 | Furcation Defects | 253 |
| 16.5.2 | Intrabony Defects | 253 |
| 16.5.3 | Root Coverage | 253 |
| 16.5.4 | Surgical Techniques | 255 |
| 16.6 | Conclusions | 258 |
| | References | 258 |
| 17 | Tissue Engineering of Teeth Misako Nakashima | 265 |
| | Abstract | 265 |
| 17.1 | Introduction | 265 |
| 17.2 | The Triad | 266 |
| 17.2.1 | Pulp Stem/Progenitor Cells | 266 |
| 17.2.1.1 | Isolation | 266 |
| 17.2.1.2 | Self-Renewal | 268 |
| 17.2.1.3 | Multipotential Differentiation | 269 |
| 17.2.2 | Morphogenetic Signals, BMPs | 269 |
| 17.2.3 | Scaffold | 270 |
| 17.3 | Dentin Regeneration | 271 |
| 17.3.1 | Protein Therapy | 271 |
| 17.3.2 | Gene Therapy | 272 |
| 17.3.2.1 | In-Vivo BMP Gene Therapy | 272 |
| 17.3.2.2 | Ex-Vivo BMP Cell Therapy and Gene Therapy | 273 |
| 17.4 | Pulp Regeneration | 276 |
| 17.4.1 | Vasculogenesis | 276 |
| 17.4.2 | Neurogenesis | 276 |
| 17.5 | Whole-Teeth Regeneration | 277 |
| 17.6 | Conclusions and Future Perspectives | 278 |
| | References | 278 |
| Part III | Pathological Calcifications | 283 |
| 18 | Aspects of Pathological Calcifications Inge Schmitz | 285 |
| | Abstract | 285 |
| 18.1 | Introduction | 285 |
| 18.1.1 | Examples of Pathological Calcification | 286 |
| 18.1.2 | Regulation of Calcifications | 287 |
| 18.2 | Heterotopic Ossification | 288 |
| 18.2.1 | Calcification in Ulcera of Patients with Paraplegia | 288 |
| 18.2.2 | Calcifications of the Lung | 289 |
| 18.2.2.1 | Metastatic Pulmonary Calcifications | 291 |
| 18.3 | Vascular Calcifications: Arteriosclerosis | 291 |
| 18.3.1 | Calcifications of Arteries | 291 |
| 18.3.1.1 | Calcification of the Tunica Media (Mönckeberg's Arteriosclerosis) | 292 |
| 18.3.1.2 | Calcification of the Tunica Intima (Arteriosclerosis) | 293 |
| 18.3.2 | Ossifications of Arteries | 294 |
| 18.3.3 | Characterization of Atherosclerotic Plaques of the Human Aorta | 294 |
| 18.4 | Calcification of Synthetic Vascular Grafts | 296 |
| 18.4.1 | Chronic Kidney Disease-Dialysis and Vascular Calcification of Arteries and Arteriovenous Shunts | 296 |
| 18.4.2 | Ossification of Synthetic Grafts | 298 |
| 18.5 | Conclusions | 299 |
| | References | 299 |
| 19 | Atherosclerosis: Cellular Aspects Diane Proudfoot and Catherine M. Shanahan | 301 |
| | Abstract | 301 |
| 19.1 | Introduction | 301 |
| 19.2 | Role of VSMCs in Vascular Calcification | 303 |
| 19.2.1 | Release of Apoptotic Bodies and Vesicles | 303 |
| 19.2.2 | Phagocytosis | 305 |
| 19.2.3 | VSMC Osteo/Chondrocytic Conversion | 306 |
| 19.2.4 | Role of Calcifying Vascular Cells and Pericytes | 309 |
| 19.3 | Role of Inflammatory Cells | 310 |
| 19.3.1 | Macrophages | 310 |
| 19.3.2 | Dendritic Cells, Mast Cells and T Lymphocytes | 312 |
| 19.4 | The Role of Osteoclasts: Is there a Possibility for Calcification-Regression? | 312 |
| 19.5 | Conclusions | 313 |
| | References | 313 |
| 20 | The Biological and Cellular Role of Fetuin Family Proteins in Biomineralization Cora Schäfer and Willi Jahnen-Dechent | 317 |
| | Abstract | 317 |
| 20.1 | Osteogenesis and Bone Mineralization versus Calcification | 317 |
| 20.2 | 2-HS Glycoprotein/Fetuin-A is a Systemic Inhibitor of Ectopic Calcification | 320 |
| 20.3 | The Mechanism of Fetuin-A Inhibition of Calcification | 322 |
| 20.4 | The Fate of Calciprotein Particles | 322 |
| | References | 325 |
| 21 | Stone Formation Pierfrancesco Bassi | 329 |
| | Abstract | 329 |
| 21.1 | Urinary Stones | 329 |
| 21.1.1 | Pathogenesis | 330 |
| 21.1.1.1 | Inhibitors of Stone Formation | 331 |
| 21.1.2 | Classification of Urinary Stones | 333 |
| 21.1.2.1 | Calcium Stones | 333 |
| 21.1.2.2 | Uric Acid Stones | 336 |
| 21.1.2.3 | Magnesium Ammonium Phosphate Stones, Struvite or Infection Stones | 337 |
| 21.1.2.4 | Cystine Stones | 338 |
| 21.1.3 | Risk Factors | 338 |
| 21.1.3.1 | Non-Genetic Factors | 338 |
| 21.1.3.2 | Genetic Factors | 341 |
| 21.2 | Other Urological Stones: Testicular Microlithiasis | 343 |
| 21.3 | Biliary and Gallbladder Stones | 343 |
| 21.4 | Miscellaneous Stones | 344 |
| 21.4.1 | Sialolithiasis | 344 |
| 21.4.2 | Dental Stones | 344 |
| 21.4.3 | Pancreatic Stones | 345 |
| 21.4.4 | Broncholithiasis and Pulmonary Alveolar Microlithiasis | 345 |
| | References | 346 |
| 22 | Ectopic Mineralization: New Concepts in Etiology and Regulation Cecilia M. Giachelli | 349 |
| | Abstract | 349 |
| 22.1 | Introduction | 349 |
| 22.2 | Regulators of Ectopic Mineralization | 350 |
| 22.2.1 | Circulating Factors that Regulate Ectopic Mineralization | 350 |
| 22.2.2 | Ion Transporters and Homeostatic Enzymes that Regulate Ectopic Mineralization | 352 |
| 22.2.2.1 | Role of Sodium-Dependent Phosphate Co-Transporters in Ectopic Mineralization | 353 |
| 22.2.3 | Extracellular Matrix Molecules that Regulate Ectopic Mineralization | 354 |
| 22.2.3.1 | Role of Osteopontin in Ectopic Mineralization | 355 |
| 22.2.4 | Cell Signaling Pathways that Regulate Ectopic Mineralization | 355 |
| 22.2.5 | Roles of Cell Death and Bone Remodeling in Ectopic Mineralization | 357 |
| 22.3 | Conclusions and Implications for Therapeutic Control of Ectopic Mineralization | 358 |
| | References | 358 |
| 23 | Pathological Calcification of Heart Valve Bioprostheses Birgit Glasmacher and Martin Krings | 361 |
| | Abstract | 361 |
| 23.1 | Introduction | 361 |
| 23.2 | In-Vitro Calcification Models | 364 |
| 23.3 | Heart Valve Bioprostheses | 364 |
| 23.4 | Calcification Hypotheses and Study Design | 364 |
| 23.5 | Calcification Imaging Methods | 365 |
| 23.6 | Calcification Patterns | 367 |
| 23.7 | Description of Findings | 369 |
| 23.8 | Conclusions and Future Research | 370 |
| | References | 371 |
| 24 | The Biomaterials Network (Biomat.net) as a Major Internet Resource for Biomaterials, Tissue Engineering and Biomineralization Pedro L. Granja, José Paulo Pereira, and Mário A. Barbosa | 373 |
| | Abstract | 373 |
| 24.1 | The Internet as a Major Healthcare Resource | 373 |
| 24.2 | Impact of Biomaterials Science in Modern Society | 375 |
| 24.3 | Biomat.net as a Biomineralization Resource | 376 |
| 24.4 | The Biomaterials Network (Biomat.net) | 383 |
| 24.4.1 | An Overview | 383 |
| 24.4.2 | Objectives | 384 |
| 24.4.3 | Team | 385 |
| 24.4.4 | Functionalities | 386 |
| 24.4.4.1 | Site Map | 387 |
| 24.4.4.2 | Membership | 387 |
| 24.4.4.3 | Links Lists | 387 |
| 24.4.4.4 | Directory of Researchers | 387 |
| 24.4.4.5 | Jobs | 388 |
| 24.4.4.6 | Newsletter | 388 |
| 24.4.4.7 | Endorsement of Scientific Meetings | 389 |
| | References | 389 |
| | Index | 391 |